Search by Drug Name or NDC
NDC 65649-0150-90 Relistor 150 mg/1 Details
Relistor 150 mg/1
Relistor is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Salix Pharmaceuticals, Inc.. The primary component is METHYLNALTREXONE BROMIDE.
MedlinePlus Drug Summary
Methylnaltrexone is used to treat constipation caused by opioid (narcotic) pain medications in people with chronic (ongoing) pain that is not caused by cancer but may be related to a previous cancer or cancer treatment. Methylnaltrexone is in a class of medications called peripherally acting mu-opioid receptor antagonists. It works by protecting the bowel from the effects of opioid (narcotic) medications.
Related Packages: 65649-0150-90Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Methylnaltrexone
Product Information
| NDC | 65649-0150 |
|---|---|
| Product ID | 65649-150_0c52697c-202f-6baa-e063-6294a90a2591 |
| Associated GPIs | 52580050100320 |
| GCN Sequence Number | 076398 |
| GCN Sequence Number Description | methylnaltrexone bromide TABLET 150 MG ORAL |
| HIC3 | H3Y |
| HIC3 Description | MU-OPIOID RECEPTOR ANTAGONISTS,PERIPHERALLY-ACTING |
| GCN | 41923 |
| HICL Sequence Number | 035611 |
| HICL Sequence Number Description | METHYLNALTREXONE BROMIDE |
| Brand/Generic | Brand |
| Proprietary Name | Relistor |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Methylnaltrexone bromide |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 150 |
| Active Ingredient Units | mg/1 |
| Substance Name | METHYLNALTREXONE BROMIDE |
| Labeler Name | Salix Pharmaceuticals, Inc. |
| Pharmaceutical Class | Opioid Antagonist [EPC], Opioid Antagonists [MoA], Quaternary Ammonium Compounds [CS] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA208271 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 65649-0150-90 (65649015090)
| NDC Package Code | 65649-150-90 |
|---|---|
| Billing NDC | 65649015090 |
| Package | 90 TABLET in 1 BOTTLE (65649-150-90) |
| Marketing Start Date | 2016-07-19 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 25.338 |
| Pricing Unit | EA |
| Effective Date | 2024-01-01 |
| NDC Description | RELISTOR 150 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis